Viemed Healthcare (NASDAQ: VMD) revenue
Viemed Healthcare reported revenue of $270.3m for fiscal 2025, 20.5% more than in fiscal 2024 ($224.3m). Since fiscal 2018 its revenue has grown by 319.3%, an average growth of 22.7% a year.
Viemed Healthcare has grown its revenue for 4 years in a row, and fiscal 2025 is the highest of its 8 fiscal years on record. The biggest drop was in fiscal 2021, −10.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $270.3m | +20.5% | $22.9m | 8.5% |
| 2024 | $224.3m | +22.5% | $17.9m | 8.0% |
| 2023 | $183.0m | +31.8% | $14.3m | 7.8% |
| 2022 | $138.8m | +18.6% | $8.3m | 5.9% |
| 2021 | $117.1m | −10.8% | $11.6m | 9.9% |
| 2020 | $131.3m | +63.6% | $26.8m | 20.4% |
| 2019 | $80.3m | +24.5% | $8.9m | 11.0% |
| 2018 | $64.5m | — | $10.1m | 15.6% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Viemed Healthcare revenue compared with its sector
By revenue for its latest fiscal year, Viemed Healthcare ranks 228th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Viemed Healthcare, 20.5%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 226th | Vericel | $276.3m | 16.5% |
| 227th | Harrow | $272.3m | 36.4% |
| 228th | Viemed Healthcare | $270.3m | 20.5% |
| 229th | Ligand Pharmaceuticals | $268.1m | 60.4% |
| 230th | Iovance Biotherapeutics | $263.5m | 60.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Viemed Healthcare
- How much revenue did Viemed Healthcare make in fiscal 2025?
- Viemed Healthcare reported revenue of $270.3m for fiscal 2025, compared with $224.3m in fiscal 2024.
- How much has the revenue of Viemed Healthcare grown?
- Between fiscal 2018 and fiscal 2025 it went from $64.5m to $270.3m: 319.3% more, an average growth of 22.7% a year.
- What was the best year for revenue at Viemed Healthcare?
- Of its last 8 fiscal years, fiscal 2025, with $270.3m.
- Where does Viemed Healthcare rank in its sector by revenue?
- It ranks 228th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Viemed Healthcare come from?
- From the annual report (Form 10-K) that Viemed Healthcare files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Viemed Healthcare files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Viemed Healthcare: the Viemed Healthcare page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.